GB201516183D0 - Novel pharmaceutical composition - Google Patents

Novel pharmaceutical composition

Info

Publication number
GB201516183D0
GB201516183D0 GBGB1516183.9A GB201516183A GB201516183D0 GB 201516183 D0 GB201516183 D0 GB 201516183D0 GB 201516183 A GB201516183 A GB 201516183A GB 201516183 D0 GB201516183 D0 GB 201516183D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
novel pharmaceutical
novel
composition
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1516183.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Calchan Ltd
Original Assignee
Calchan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calchan Ltd filed Critical Calchan Ltd
Priority to GBGB1516183.9A priority Critical patent/GB201516183D0/en
Publication of GB201516183D0 publication Critical patent/GB201516183D0/en
Priority to PCT/GB2016/052833 priority patent/WO2017046581A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1516183.9A 2015-09-14 2015-09-14 Novel pharmaceutical composition Ceased GB201516183D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1516183.9A GB201516183D0 (en) 2015-09-14 2015-09-14 Novel pharmaceutical composition
PCT/GB2016/052833 WO2017046581A1 (en) 2015-09-14 2016-09-14 Composition comprising cav2.2 calcium channel blocker and opioid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1516183.9A GB201516183D0 (en) 2015-09-14 2015-09-14 Novel pharmaceutical composition

Publications (1)

Publication Number Publication Date
GB201516183D0 true GB201516183D0 (en) 2015-10-28

Family

ID=54363082

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1516183.9A Ceased GB201516183D0 (en) 2015-09-14 2015-09-14 Novel pharmaceutical composition

Country Status (2)

Country Link
GB (1) GB201516183D0 (en)
WO (1) WO2017046581A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008534630A (en) * 2005-04-08 2008-08-28 ニューロメッド ファーマシューティカルズ リミテッド Method of combination therapy including N-type calcium channel blockers for pain relief
GB0813142D0 (en) * 2008-07-17 2008-08-27 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
WO2017046581A1 (en) 2017-03-23

Similar Documents

Publication Publication Date Title
IL265360A (en) Pharmaceutical composition
IL265260B (en) Pharmaceutical composition
GB201409471D0 (en) Pharmaceutical composition
IL262654A (en) Pharmaceutical composition
GB201409488D0 (en) Pharmaceutical composition
IL265349A (en) Pharmaceutical composition
GB201409485D0 (en) Pharmaceutical composition
SI3278801T1 (en) Pharmaceutical composition containing mirabegron
GB201521462D0 (en) Pharmaceutical composition
GB201615917D0 (en) Pharmaceutical composition
GB201515310D0 (en) Pharmaceutical composition
HK1245073A1 (en) Pharmaceutical compositions
PL3454838T3 (en) Pharmaceutical composition
GB201520862D0 (en) Pharmaceutical composition
GB201615914D0 (en) Pharmaceutical composition
GB201615910D0 (en) Pharmaceutical composition
SI3089740T1 (en) Pharmaceutical composition
IL265436B (en) Pharmaceutical composition
GB201620519D0 (en) Pharmaceutical composition
SG10201504332VA (en) Pharmaceutical Composition
IL265428A (en) Pharmaceutical composition
PT3476391T (en) Pharmaceutical composition
GB201620516D0 (en) Pharmaceutical composition
GB201620517D0 (en) Pharmaceutical composition
GB201620513D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)